Nebulizer Market to Reach USD 1,275.1 Million by 2030; Increasing Incidences of Respiratory Disorders to Foster Market Growth

The global nebulizer market size is expected to exhibit strong growth by reaching USD 1,275.1 million by 2030, exhibiting a CAGR of 5.2% during the forecast period. Fortune Business Insights™ in its report titled “Nebulizer Market Size, Share, and COVID-19 Impact Analysis, By Type (Jet Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer), By Modality (Table-top, and Portable), By End-user (Hospitals, Clinics, and Homecare Settings), and Regional Forecasts, 2023-2030” observes that the market size in 2022 stood at USD 863.4 million and touched USD 897.0 million in 2023. Rising respiratory disorders and strong demand for innovative respiratory drug delivery may enhance the industry’s growth.

OMRON Healthcare, Inc. Undertook the Expansion of its Prescription-Grade Nebulizers to Expand Market Reach

OMRON Healthcare, Inc. undertook the expansion of its prescription-grade nebulizers in October 2020. The product is quiet, compact, portable, and allows patients to manage Chronic Obstructive Pulmonary Disease (COPD) and asthma. This strategy may enable the company to enhance its brand image.

Increasing Respiratory Disorders to Foster Market Growth

Nebulizers are drug delivery devices responsible for delivering medicines in the form of a mist in the lungs. Increasing respiratory disorders may foster the adoption of medical devices. For example, as per the Asthma and Allergy Foundation of America’s strategy, in April 2022, nearly 25.0 million people in the U.S. suffered from asthma. Rising pollution, poor air quality, and the presence of several factories may elevate the adoption of the device. Further, increasing healthcare costs bolstered the adoption of home healthcare services, thereby elevating this industry’s progress. In addition, strong adoption of inhaled drug delivery devices may drive the nebulizer market growth.

Major Players Deploy Collaborations to Boost their Brand Image

The key players operating in the market deploy acquisition strategies to elevate their brand image. For example, PARI GmbH partnered with TWT Digital Health (TWT) in July 2021 to develop the PARI connect application. This application also offers Bluetooth communication with the eTrack controller, a controller unit for PARI’s eFlow Technology nebulizer. Further, numerous players deploy mergers, novel product launches, partnerships, research & development, acquisitions, innovations, and industrial automation to enhance their market position.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/nebulizers-market-100707

Notable Industry Development

• March 2021: PARI Pharma GmbH announced the authorization of its LAMIRA Nebulizer System to offer Insmed’s ARIKAYCE in Japan.

List of Key Players Profiled in the Report

• OMRON Healthcare, Inc. (Japan)


• Koninklijke Philips N.V. (Netherlands)


• PARI Respiratory Equipment, Inc. (U.S.)


• DeVilbiss Healthcare LLC (U.S.)


• Briggs Healthcare (U.S.)


• GF HEALTH PRODUCTS, INC. (U.S.)


• Trudell Medical International (Canada)


• Allied Healthcare Products, Inc. (U.S.)


• Teleflex Medical, Inc. (U.S.)

Further Report Findings

• The market in North America stood at USD 394.6 million in 2022 and is expected to gain a huge portion of the global nebulizer market share in the coming years. Furthermore, a higher prevalence of asthma is expected to enhance the adoption of the device.


• Further, the increasing prevalence of asthma is likely to enhance the demand for medical devices.


• In Europe, the rising prevalence of respiratory diseases is expected to boost the industry’s growth.

Table of Segmentation